Article Details
Retrieved on: 2022-01-15 15:57:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New York: Pfizer Inc. has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved CIBINQO (abrocitinib), an oral, ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here